Kymera Therapeutics Q3 Net Loss Widens
Kymera Therapeutics reported a wider net loss for the third quarter.
Related stories
FTI Consulting Reports Record Q3 Revenue, Raises EPS Guidance
FTI Consulting said third-quarter revenue reached a record, adjusted EPS rose 48%, and it raised its full-year adjusted EPS guidance. Shares jumped 11.7% in afternoon trading.
M impact | EQUITY | Oct 29, 2026, 05:41 PM UTC
Polymarket Investigates Suspicious Trades on Israeli Election
A person familiar with the matter said the trades were well-timed and profitable. The investigation comes amid scrutiny of potential insider trading on prediction-market platforms.
L impact | EQUITY | Oct 29, 2026, 05:40 PM UTC
General Motors to Pay $220 Million in Data Privacy Settlement
General Motors agreed to pay $220 million to settle a drivers' data privacy matter.
M impact | EQUITY | Oct 29, 2026, 05:39 PM UTC
Rapala VMC Q1–Q3 Sales Rise 6%, Comparable Operating Profit Improves
Net sales increased 6% year over year (8% organically), and comparable operating profit rose to €15.5 million from €10.1 million. North America grew 11%, while Europe declined 1%;
M impact | EQUITY | Oct 29, 2026, 05:37 PM UTC
Rapala VMC Q3 comparable operating profit was 2.0 MEUR
Q3 comparable operating profit was 2.0 MEUR, versus 1.5 in the prior comparison.
M impact | EQUITY | Oct 29, 2026, 05:37 PM UTC
eBay shares rise 3.82% to $122.53
eBay shares rose 3.82% to $122.53 at noon ET on October 29. The move followed its third-quarter results and higher analyst price targets.
M impact | EQUITY | Oct 29, 2026, 05:36 PM UTC